BOLT CIK: 1641281

Bolt Biotherapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−92.8
FY22:
−90.3
FY23:
−76.2
FY24:
−73.0
FY25:
−36.1
(positive)
Change from FY21 to FY23
millions USD
FY21:
−85.5
FY22:
−88.7
FY23:
−74.3
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−98.6
FY22:
−88.1
FY23:
−69.2
FY24:
−63.1
FY25:
−33.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−98.6
FY22:
−88.1
FY23:
−69.2
FY24:
−63.1
FY25:
−33.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data